XML 36 R25.htm IDEA: XBRL DOCUMENT v3.21.2

Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2021

Summary of Significant Accounting Policies

Schedule of disaggregation of revenue by major source

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended September 30,

​

Nine Months Ended September 30,

​

2021

2020

2021

2020

Biopharma/Pharma

​

$

46,001

​

$

9,760

​

$

133,878

​

$

27,120

Animal Health

​

8,261

​

223

​

25,655

​

664

Reproductive Medicine

​

​

2,431

​

​

1,189

​

​

6,635

​

​

2,551

Total revenues

​

$

56,693

​

$

11,172

​

$

166,168

​

$

30,335

Schedule of geographical revenues, by origin

​

​	​	​	​	​	​	​	​	​	​	​	​	​
​	​	Three Months Ended September 30,					​	Nine Months Ended September 30,
​		2021			2020			2021			2020
Americas	​	$	30,307	​	$	8,750	​	$	87,177	​	$	23,837
Europe, the Middle East and Africa (EMEA)	​		14,382	​		2,009	​		43,632	​		5,704
Asia Pacific (APAC)	​		12,004	​		413	​		35,359	​		794
Total revenues	​	$	56,693	​	$	11,172	​	$	166,168	​	$	30,335

Schedule of net loss per share

The following shows the amounts used in computing net loss per share (in thousands except per share data):

​

​	​	​	​	​	​	​	​	​	​	​	​	​
​	​	Three Months Ended September 30,					​	Nine Months Ended September 30,
​		2021			2020			2021			2020
Net loss	​	$	(6,526)	​	$	(11,418)	​	$	(15,442)	​	$	(21,164)
Paid-in-kind dividend on Series C convertible preferred stock	​		(2,000)	​		—	​		(6,196)	​		—
Net loss attributable to common shareholders	​	$	(8,526)	​	$	(11,418)	​	$	(21,638)	​	$	(21,164)
Weighted average common shares issued and outstanding - basic and diluted	​	​	46,137,147	​	​	39,144,916	​	​	45,220,319	​	​	38,211,327
Basic and diluted net loss per share	​	$	(0.18)	​	$	(0.29)	​	$	(0.48)	​	$	(0.55)

​

Schedule of number of shares excluded from the computation of diluted loss per share

The following table sets forth the number of shares excluded from the computation of diluted loss per share, as their inclusion would have been anti-dilutive:

​

​	​	​	​	​	​	​	​	​
​	​	Three Months Ended September 30,			​	Nine Months Ended September 30,
​		2021		2020		2021		2020
Stock options		5,727,495		5,823,629	​	5,673,387		4,932,353
Restricted stock units	​	361,791	​	—	​	361,791	​	—
Series C convertible preferred stock	​	5,283,411	​	—	​	5,283,411	​	—
Convertible senior notes		4,810,002		4,810,002	​	4,810,002		4,810,002
​		16,182,699		10,633,631	​	16,128,591		9,742,355

​

X

- References

No definition available.

+ Details

Name:	us-gaap_AccountingPoliciesAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph a
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599

+ Details

Name:	us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

+ Details

Name:	us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration